HALO logo
halo search icon
TScan Therapeutics, Inc.

US$0.99

Price Change Indicator
0.032 (3.27%)
TScan Therapeutics, Inc.
TCRX · NAS

TScan Therapeutics, Inc.

Start Trading TCRX for Free

US$0.99

Price Arrow0.032 (3.27%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus ValueRecent Earnings downgradeRecent Price upgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

TScan Therapeutics, Inc. Overview

TCRX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About TCRX

icon

Website

TScan Therapeutics, Inc.

icon

Telephone

1.857.399.9500

icon

Address

830 Winter Street, Waltham, MA 02451

Description

TScan Therapeutics, Inc. discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors and other serious diseases. Its platform identifies previously uncharacterized, clinically-derived shared T cell antigens and all off-target TCR interactions, to enable the development of efficacious TCR-Ts. The company was founded by Christoph H. Westphal, Stephen Elledge, Lea Hachigian, and Tomasz Kula in 2018 and is headquartered in Boston, MA.

TCRX Price Chart

Key Stats

Market Cap

US$58.82M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.88 - 2.57

Trade Value (12mth)

US$215,986.00

1 week

-3.69%

1 month

-24.17%

YTD

-5.58%

1 year

-27.04%

All time high

14.71

Key Fundamentals

EPS 3 yr Growth

-63.70%

EBITDA Margin

NaN%

Operating Cashflow

-$136m

Free Cash Flow Return

-50.00%

ROIC

-47.70%

Interest Coverage

-48.00

Quick Ratio

8.40

Other Data

Shares Outstanding (Fully Diluted)

130m

HALO Sector

Healthcare

Next Company Report Date

10-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

TCRX Announcements

Latest Announcements

DateAnnouncements
06 May 26
06 May 26
06 May 26
06 May 26
02 April 26

TCRX Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-1.36-1.14-1locklocklock
EPS (Fully Diluted)
 $locklocklocklock-1.36-1.14-1locklocklock
Growth
 %locklocklocklock50.616.312.2locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of TScan Therapeutics, Inc. (TCRX:NAS)?
Halo FAQ
The current share price of TScan Therapeutics, Inc. (TCRX:NAS) is USD$0.99.
What is the 52-week high share price for TScan Therapeutics, Inc. (TCRX:NAS)?
Halo FAQ
The 52-week high share price for TScan Therapeutics, Inc. (TCRX:NAS) is USD$2.57.
What is the 52-week low share price for TScan Therapeutics, Inc. (TCRX:NAS)?
Halo FAQ
The 52-week low share price for TScan Therapeutics, Inc. (TCRX:NAS) is USD$0.88.
What is the dividend yield for TScan Therapeutics, Inc. (TCRX:NAS)?
Halo FAQ
TScan Therapeutics, Inc. (TCRX:NAS) does not pay a dividend.
What was TScan Therapeutics, Inc. (TCRX:NAS) last dividend payment?
Halo FAQ
TScan Therapeutics, Inc. (TCRX:NAS) does not pay a dividend.
What is the franking level for TScan Therapeutics, Inc. (TCRX:NAS)?
Halo FAQ
TScan Therapeutics, Inc. (TCRX:NAS) has a franking level of 0.00%.
In which sector is TScan Therapeutics, Inc. (TCRX:NAS) classified?
Halo FAQ
TScan Therapeutics, Inc. (TCRX:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial